Dashboard
1
Company has very low debt and has enough cash to service the debt requirements
2
Poor long term growth as Net Sales has grown by an annual rate of -3.28% and Operating profit at -7.06% over the last 5 years
3
Flat results in Jun 25
4
With ROE of 10.03%, it has a very attractive valuation with a 1.22 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
JPY 5,211 Million (Micro Cap)
12.00
NA
0.00%
-0.35
10.08%
1.28
Revenue and Profits:
Net Sales:
518 Million
(Quarterly Results - Jun 2025)
Net Profit:
63 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.71%
0%
1.71%
6 Months
5.64%
0%
5.64%
1 Year
28.66%
0%
28.66%
2 Years
49.91%
0%
49.91%
3 Years
46.04%
0%
46.04%
4 Years
-3.68%
0%
-3.68%
5 Years
0%
0%
0.0%
TOWA Hi SYSTEM Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News

TOWA Hi SYSTEM Adjusts Stock Rating to 'Hold' Amid Mixed Technical Indicators
TOWA Hi SYSTEM Co., Ltd. has recently been rated as 'Hold' following an evaluation adjustment. This change reflects a complex analysis of the company's technical indicators, which show mixed trends. Despite facing financial challenges, the company maintains a low debt profile and adequate cash reserves.
Read More Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-3.28%
EBIT Growth (5y)
-7.06%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.44
Sales to Capital Employed (avg)
0.54
Tax Ratio
32.02%
Dividend Payout Ratio
48.79%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.67%
ROE (avg)
9.43%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
1.22
EV to EBIT
6.35
EV to EBITDA
5.48
EV to Capital Employed
1.39
EV to Sales
1.43
PEG Ratio
0.15
Dividend Yield
NA
ROCE (Latest)
21.80%
ROE (Latest)
10.03%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
518.10
625.50
-17.17%
Operating Profit (PBDIT) excl Other Income
93.00
195.50
-52.43%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
63.30
142.30
-55.52%
Operating Profit Margin (Excl OI)
137.70%
279.80%
-14.21%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -17.17% vs 2.31% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -55.52% vs 5.41% in Mar 2025
Annual Results Snapshot (Consolidated) - Sep'24
Sep'24
Sep'23
Change(%)
Net Sales
2,114.10
2,041.70
3.55%
Operating Profit (PBDIT) excl Other Income
500.80
299.40
67.27%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
401.80
258.50
55.44%
Operating Profit Margin (Excl OI)
199.70%
113.10%
8.66%
USD in Million.
Net Sales
YoY Growth in year ended Sep 2024 is 3.55% vs -7.84% in Sep 2023
Consolidated Net Profit
YoY Growth in year ended Sep 2024 is 55.44% vs -18.27% in Sep 2023
About TOWA Hi SYSTEM Co., Ltd. 
TOWA Hi SYSTEM Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






